Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
04/04/2000 | US6046310 Fas protein recognition moiety of extracellular domain of fas ligand protein fused to polypeptide which specifically binds cell surface marker; for immunosuppressants and treatment of autoimmune disorders; antidiabetic/antiarthritic agents |
04/04/2000 | US6046309 Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
04/04/2000 | US6046308 Isolated TRBP polypeptides and uses therefor |
04/04/2000 | US6046307 Modulation of mammalian telomerase by peptide nucleic acids |
04/04/2000 | US6046306 PNA synthesis using an amino protecting group which is labile to weak acids |
04/04/2000 | US6046289 For inhibiting coagulation of blood platelets, inhibiting adhesion of animal cells, or as substrate for culturing animal cells |
04/04/2000 | US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae |
04/04/2000 | US6046166 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
04/04/2000 | US6046165 Compositions and methods for identifying and testing TGF-β pathway agonists and antagonists |
04/04/2000 | US6046162 Suppression of cell proliferation by decorin |
04/04/2000 | US6046158 Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof |
04/04/2000 | US6046157 Modulation of TGF-β by recombinant TGF-β type II receptor polypeptides |
04/04/2000 | US6046048 Apo-2 ligand |
04/04/2000 | US6046047 Genetic construct encoding a chimeric protein with a domain which binds and crosslinks a synthetic, membrane permeable, non-peptide ligand and domain to cause cellular localization of complex; for gene therapy and inducible gene expression |
04/04/2000 | US6046044 Cisplatin resistance proteins |
04/04/2000 | US6046037 Method for producing immunoglobulins containing protection proteins in plants and their use |
04/04/2000 | US6046035 Polynucleotides encoding a cardiotrophin-like cytokine |
04/04/2000 | US6046034 Thermostable variants of human interferon-γ(IFN-γ) |
04/04/2000 | US6046033 Basic osteoblast growth factor II (bOGF-II) |
04/04/2000 | US6046031 Metalloproteinases |
04/04/2000 | US6046030 For the treatment of neurological disorders such as alzheimer's disease, multiple sclerosis and abnormal neural development; endocrine disorders such as diabetes; and heart disease, among others and diagnostic assays for such |
04/04/2000 | US6046028 Polynucleotides encoding insulin homolog zins3 |
04/04/2000 | US6046027 Human retinoid binding protein |
04/04/2000 | US6046026 cDNAs encoding proteins closely related to opioid receptors |
04/04/2000 | US6046025 Expression of heterologous proteins in drosophila cells |
04/04/2000 | US6046024 Method of producing a fibrin monomer using a biotinylated enzyme and immobilized avidin |
04/04/2000 | US6046015 Modulating Robo: ligand interactions |
04/04/2000 | US6046014 Phytofluors as fluorescent labels |
04/04/2000 | US6046011 Mammalian adrenocorticotropic hormone receptors and uses |
04/04/2000 | US6046007 Administering to the subject an effective amount of a polypeptide having crma biological activity and under suitable conditions such that t cells remain viable. |
04/04/2000 | US6045999 Transcription factor E2F-4 |
04/04/2000 | US6045997 Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof |
04/04/2000 | US6045831 Nuclear inhibitor I-92 and its use for the production of a medicament |
04/04/2000 | US6045803 Administering to an avian a recombinant herpesvirus of turkeys for expressing an antigenic polypeptide to treat viral diseases |
04/04/2000 | US6045802 Antitumor agents treating cancer |
04/04/2000 | US6045801 Hair growers having actions of promoting proliferation of hair papilla cells |
04/04/2000 | US6045799 Inducing infertility in a mammal by administering a recombinant chimeric protein in a diluent, adjuvant or carrier |
04/04/2000 | US6045798 Membrane-associated immunogens of mycobacteria |
04/04/2000 | US6045797 Treatment or diagnosis of diseases or conditions associated with a BLM domain |
04/04/2000 | US6045796 Vaccination with peptide of MHC class II molecules for treatment of autoimmune disease |
04/04/2000 | CA2173878C Polynucleotide for treating systemic lupus erythematosus |
04/04/2000 | CA2155933C Pulmonary administration of scr1 and other complement inhibitory proteins |
04/04/2000 | CA2127331C Motilin-like polypeptides that inhibit gastrointestinal motor activity |
04/04/2000 | CA2048676C Artificial promoter for the expression of proteins in yeast |
04/04/2000 | CA2034425C Method for inhibiting bacteria using a novel lactococcal bacteriocin |
04/04/2000 | CA1340948C Peptidylaminodiols |
04/04/2000 | CA1340942C Processes for the treatment of vascular disease |
04/04/2000 | CA1340940C Peptidylaminodiols |
04/01/2000 | CA2246005A1 Hybrid genes for gene therapy in erythroid cells |
03/30/2000 | WO2000017650A1 Energy transfer compositions comprising phycobiliproteins |
03/30/2000 | WO2000017647A1 DIAGNOSTIC ASSAYS FOR DETECTION OF $i(CRYPTOSPORIDIUM PARVUM) |
03/30/2000 | WO2000017641A1 Gpr10 as a target for identifying weight modulating compounds |
03/30/2000 | WO2000017383A1 Factor v leiden detection |
03/30/2000 | WO2000017382A1 Methods and compositions relating to bone-derived growth factor-like polypeptides |
03/30/2000 | WO2000017376A1 Replication deficient retroviral vector system and methods of using |
03/30/2000 | WO2000017374A1 Retroviral particles protected against complement mediated destruction |
03/30/2000 | WO2000017373A1 Recombinant celo virus and celo virus dna |
03/30/2000 | WO2000017372A2 Pineapple mealybug-associated wilt virus proteins and their uses |
03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
03/30/2000 | WO2000017369A2 Alzheimer's disease secretase |
03/30/2000 | WO2000017365A2 Binary viral expression system in plants |
03/30/2000 | WO2000017364A2 Cyclin d polynucleotides, polypeptides and uses thereof |
03/30/2000 | WO2000017363A2 Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses |
03/30/2000 | WO2000017362A1 Human interleukin-b50, therapeutic uses |
03/30/2000 | WO2000017361A2 Interferon-epsilon |
03/30/2000 | WO2000017360A1 Cystine knot growth factor mutants |
03/30/2000 | WO2000017359A1 Novel cartilage-associated polynucleotides, polypeptides encoded thereby, and uses thereof |
03/30/2000 | WO2000017358A2 Human chaperone proteins |
03/30/2000 | WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides |
03/30/2000 | WO2000017356A2 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof |
03/30/2000 | WO2000017355A2 Human cytoskeleton associated proteins |
03/30/2000 | WO2000017354A1 Human isre-binding protein |
03/30/2000 | WO2000017353A1 Ucp4 |
03/30/2000 | WO2000017351A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
03/30/2000 | WO2000017350A1 New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
03/30/2000 | WO2000017349A1 A HUMAN Hsg III GENE |
03/30/2000 | WO2000017348A1 G protein-coupled receptor agonists or antagonists |
03/30/2000 | WO2000017347A1 Camelid sex specific polynucleotide sequences |
03/30/2000 | WO2000017345A1 Ly6h gene |
03/30/2000 | WO2000017344A1 RESPONSE REGULATOR $i(CaSSK1) |
03/30/2000 | WO2000017339A1 Method for the diagnosis of cell proliferative disease |
03/30/2000 | WO2000017337A1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
03/30/2000 | WO2000017334A2 Analysis of ligand activated nuclear receptors i(in vivo) |
03/30/2000 | WO2000017328A2 Fibrils |
03/30/2000 | WO2000017240A1 Hmw endostatin for inhibiting the growth of tumours and capillary proliferation and for diagnosing vascular and tumour diseases |
03/30/2000 | WO2000017239A1 Purification of fibrinogen from fluids by precipitation and hydrophobic chromatography |
03/30/2000 | WO2000017238A1 Protein having cell proliferation promoting effect |
03/30/2000 | WO2000017237A1 Cerebral organic anion transporter and its gene |
03/30/2000 | WO2000017236A2 Apoptosis related protein and uses therefor |
03/30/2000 | WO2000017235A2 Cytokine receptor zalpha11 |
03/30/2000 | WO2000017234A1 Purification of fibrinogen from milk by use of cation exchange chromatography |
03/30/2000 | WO2000017233A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
03/30/2000 | WO2000017232A2 Regulatory protein from human keratinocytes |
03/30/2000 | WO2000017227A1 Method for purification of alpha-1 proteinase inhibitor |
03/30/2000 | WO2000017225A2 A small protein that interacts with a ribonucleotide reductase subunit and uses thereof |
03/30/2000 | WO2000017222A1 31 human secreted proteins |
03/30/2000 | WO2000016800A2 Methods of treating chronic pain |
03/30/2000 | WO2000016799A1 Methods of treating chronic pain |
03/30/2000 | WO2000016796A1 Chemokine receptor antagonist and cyclosporin in combined therapy |
03/30/2000 | WO2000016746A2 Immunogenic liposome compositions |